Shkreli Seeks Escape From KaloBios Securities Litigation
Pharmaceutical executive Martin Shkreli filed a motion to dismiss a putative securities class action related to his brief tenure at KaloBios Pharmaceuticals on Tuesday, saying the California litigation was sparked by...To view the full article, register now.
Already a subscriber? Click here to view full article